Document
Academic Article
Generically Dependent Continuant
RDF description of Phase II study of perifosine and sorafenib dual-targeted therapy in patients with relapsed or refractory lymphoproliferative diseases - http://irises.unibs.it/resource/item/81926
Article
Phase II study of perifosine and sorafenib dual-targeted therapy in patients with relapsed or refractory lymphoproliferative diseases
Information Content Entity